Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Lichtenauer

Showing results (41-50 of 272) with videos related to

Pageof 28
Sort By:
Journal of Cardiovascular Development and Disease|August 25, 2022
Tei Index Is a Useful Adjunctive Tool in the Diagnostic Workup of Patients with Acute MyocarditisMoritz Mirna, Lukas Schmutzler, Fabian Vogl, et al.
European Journal of Internal Medicine|March 25, 2018
Model for End-Stage Liver Disease Excluding INR (MELD-XI) score is associated with hemodynamic impairment and predicts mortality in critically ill patientsBernhard Wernly, Michael Lichtenauer, Namkje Vellinga, et al.
Minerva Medica|October 20, 2018
Triple therapy: worth the risk?Bernhard Wernly, Michael Lichtenauer, Uta C Hoppe, et al.
The Canadian Journal of Cardiology|March 2, 2016
First Autopsy Description of Changes 1 Year After Implantation of a Leadless Cardiac Pacemaker: Unexpected Ingrowth and Severe Chronic InflammationAlexander Kypta, Hermann Blessberger, Juergen Kammler, et al.
Biomedicines|August 29, 2024
Low Levels of Adropin Predict Adverse Clinical Outcomes in Outpatients with Newly Diagnosed Prediabetes after Acute Myocardial InfarctionTetiana A Berezina, Oleksandr O Berezin, Uta C Hoppe, et al.
Digestive Diseases and Sciences|June 20, 2023
sST2 Levels Show No Association with Helicobacter pylori Infection in Asymptomatic Patients: Implications for Biomarker ResearchSarah Wernly, Vera Paar, Andreas Völkerer, et al.
Expert Review of Molecular Diagnostics|July 15, 2024
An overview of circulating and urinary biomarkers capable of predicting the transition of acute kidney injury to chronic kidney diseaseAlexander E Berezin, Tetiana A Berezina, Uta C Hoppe, et al.
Biomedicines|August 29, 2024
Trajectory of Irisin as a Predictor of Kidney-Related Outcomes in Patients with Asymptomatic Heart FailureTetiana A Berezina, Oleksandr O Berezin, Uta C Hoppe, et al.
Biomolecules|January 8, 2025
Irisin Predicts Poor Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction and Low Levels of N-Terminal Pro-B-Type Natriuretic PeptideTetiana A Berezina, Oleksandr O Berezin, Evgen V Novikov, et al.
Diagnostics (Basel, Switzerland)|August 29, 2024
Adropin Predicts Asymptomatic Heart Failure in Patients with Type 2 Diabetes Mellitus Independent of the Levels of Natriuretic PeptidesTetiana A Berezina, Oleksandr O Berezin, Uta C Hoppe, et al.
Pageof 28

Showing results (41-50 of 272) with videos related to

Sort By:
Pageof 28
Journal of Cardiovascular Development and Disease|August 25, 2022
Tei Index Is a Useful Adjunctive Tool in the Diagnostic Workup of Patients with Acute MyocarditisMoritz Mirna, Lukas Schmutzler, Fabian Vogl, et al.
European Journal of Internal Medicine|March 25, 2018
Model for End-Stage Liver Disease Excluding INR (MELD-XI) score is associated with hemodynamic impairment and predicts mortality in critically ill patientsBernhard Wernly, Michael Lichtenauer, Namkje Vellinga, et al.
Minerva Medica|October 20, 2018
Triple therapy: worth the risk?Bernhard Wernly, Michael Lichtenauer, Uta C Hoppe, et al.
The Canadian Journal of Cardiology|March 2, 2016
First Autopsy Description of Changes 1 Year After Implantation of a Leadless Cardiac Pacemaker: Unexpected Ingrowth and Severe Chronic InflammationAlexander Kypta, Hermann Blessberger, Juergen Kammler, et al.
Biomedicines|August 29, 2024
Low Levels of Adropin Predict Adverse Clinical Outcomes in Outpatients with Newly Diagnosed Prediabetes after Acute Myocardial InfarctionTetiana A Berezina, Oleksandr O Berezin, Uta C Hoppe, et al.
Digestive Diseases and Sciences|June 20, 2023
sST2 Levels Show No Association with Helicobacter pylori Infection in Asymptomatic Patients: Implications for Biomarker ResearchSarah Wernly, Vera Paar, Andreas Völkerer, et al.
Expert Review of Molecular Diagnostics|July 15, 2024
An overview of circulating and urinary biomarkers capable of predicting the transition of acute kidney injury to chronic kidney diseaseAlexander E Berezin, Tetiana A Berezina, Uta C Hoppe, et al.
Biomedicines|August 29, 2024
Trajectory of Irisin as a Predictor of Kidney-Related Outcomes in Patients with Asymptomatic Heart FailureTetiana A Berezina, Oleksandr O Berezin, Uta C Hoppe, et al.
Biomolecules|January 8, 2025
Irisin Predicts Poor Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction and Low Levels of N-Terminal Pro-B-Type Natriuretic PeptideTetiana A Berezina, Oleksandr O Berezin, Evgen V Novikov, et al.
Diagnostics (Basel, Switzerland)|August 29, 2024
Adropin Predicts Asymptomatic Heart Failure in Patients with Type 2 Diabetes Mellitus Independent of the Levels of Natriuretic PeptidesTetiana A Berezina, Oleksandr O Berezin, Uta C Hoppe, et al.
Pageof 28